Drugs / NuvaRing
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | NUVARING | — | 2001-10-03 | fda.gov ↗ |
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT05360576 | Feb → Jul 2022 | — | Lupin Research Inc | Completed | No outcome recorded |
| Phase 43 trials | ||||||
| Phase 4 | NCT02445989 | May 2016 → Nov 2018 | HIV infectious disease, bacterial vaginosis | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT02432404 | Mar 2016 → Nov 2021 | bacterial vaginosis | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT02367833 | Jan 2015 → Dec 2017 | bone disorder | Penn State University | Completed | No outcome recorded |
| Phase not applicable5 trials | ||||||
| — | NCT01266759 | Jul 2008 → Sep 2010 | menstrual disorder | Mansoura University | Completed | No outcome recorded |
| — | NCT00565240 | Nov 2007 → Sep 2009 | — | University of Saskatchewan | Completed | No outcome recorded |
| — | NCT00369967 | Feb 2007 → Jul 2009 | — | Virginia Commonwealth University | Terminated | No outcome recorded |
| — | NCT00374387 | Sep 2006 → Aug 2009 | — | University Hospital, Ghent | Completed | No outcome recorded |
| — | NCT01298128 | Feb 2006 → Mar 2010 | infertility disorder | University of Toronto | Terminated | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00710606 Comparator | Jun → Dec 2008 | — | Columbia University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 10 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nuvaring | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00374387 ↗ |
| Known as | Contraceptive Vaginal Ring | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02367833 ↗ |
| Modality | Other / unclassified | “It is a combined hormonal contraceptive containing etonogestrel (a progesterone) and ethinyl estradiol (an estrogen)” NCT00369967 ↗ |
| Route | Other | “One of the biggest obstacles to use of the contraceptive vaginal ring in clinical practice is having the patient overcome the idea of vaginally inserting the ring” NCT00369967 ↗ |